Overactive Bladder (OAB) Therapy Market Worth $1.5 Billion

Global Overactive Bladder (OAB) Therapy Market

Dublin, July 19, 2024 (GLOBE NEWSWIRE) — The “Overactive Bladder (OAB) Therapeutics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offer.

The global market for Overactive Bladder (OAB) Therapy is estimated to reach US$1.2 Billion in 2023 and is projected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.8% from 2023 to 2030. This comprehensive report provides in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth of the OAB therapeutics market is driven by several factors. Technological advancements in drug formulations and drug delivery systems are making treatments more effective and user-friendly, driving demand. An aging global population, which is more susceptible to OAB, is expanding the addressable market significantly. Rising awareness and diagnosis rates of OAB, driven by educational campaigns and better diagnostic tools, are leading to higher adoption of treatments.

Additionally, the increasing prevalence of lifestyle diseases such as diabetes and obesity, which are risk factors for OAB, is contributing to the market growth. Pharmaceutical companies are investing heavily in research and development to introduce novel therapies with superior efficacy and safety profiles. Integration of digital health solutions is improving patient engagement and adherence to treatment regimens.

Furthermore, favorable reimbursement policies and improving healthcare infrastructure, especially in emerging markets, support market expansion. The collective impact of these factors is driving robust growth in the OAB therapy market, ensuring better management and improved quality of life for affected individuals.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Anticholinergic Therapy segment, which is estimated to reach US$614.7 Mn by 2030 at a CAGR of 3.1%. The Neurostimulation Therapy segment is also estimated to grow at a CAGR of 2.4% during the analysis period.

• Regional Analysis: Gain insights into the US market, estimated to reach $332.3 Million by 2023, and China, estimated to grow at an impressive CAGR of 4.8% to reach $290.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecast in US$ Million from 2023 to 2030.

• In-depth Regional Analysis: Detailed insights into key markets, including the US, China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

• Company Profiles: Coverage of key players such as Allergan PLC, Astellas Pharma, Inc., Dr. Reddy’s Laboratories Ltd., and more.

• Free Updates: Get one year of free report updates to keep you informed on the latest market developments.

The story continues

Key Attributes:

MARKET OVERVIEW

• Influencer Market Insights

• Global Economic Update

• Overactive Bladder (OAB) Therapy – Global Key Competitors Market Share Percentage by 2024 (E)

• Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide by 2024 (E)

MARKET TRENDS AND DRIVERS

• Aging Global Population Expands Addressable Market Opportunity for OAB Therapies

• Innovation in Drug Delivery Systems Drives Growth of OAB Treatment Solutions

• Personalized Medicine Highlights Tailored OAB Therapy Approach

• Advances in Neuromodulation Techniques Strengthen the Business Case for Non-Pharmacological Interventions

• Increasing Awareness and Diagnosis Rates Drive Adoption of OAB Treatments

• Rising Prevalence of Lifestyle Diseases Creates Demand for OAB Therapy

• Digital Health Technology Integration Accelerates Real-Time Symptom Management Demand

• Combination Therapy Development Improves Comprehensive Symptom Control

• Better Diagnostic Tools, Early Detection and Better Treatment

• Technological Advances in Extended Release Formulations Sustain OAB Market Growth

• Consumer Preference for Non-Invasive Treatments Expands Alternative Therapies Market

• Economic Burden of Untreated OAB Drives Demand for Effective Management Solutions

• Impact of Telemedicine Services on Improving Patient Access and Adherence to Treatment

FOCUS ON SELECTED PLAYERS(Total 34 Seeds):

• Allergan Electric Company

• Astellas Pharma, Inc.

• Dr. Reddy’s Laboratories Ltd.

• Eli Lilly and Company

• Endo Pharmaceuticals, Inc.

• Hisamitsu Pharmaceutical Co., Inc.

• Novartis Pharmaceutical Company

• Pfizer, Inc.

• Records SpA

• European Pharma Ltd. Specialization

• Sunovion Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/90f0cb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide up-to-date data on international and regional markets, key industries, leading companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900